Chapter
4 Normal Ranges of Neopterin Concentrations in Various Body Fluids
pp.：
37 – 39
4.1 Normal ranges of neopterin concentrations in urine
pp.：
39 – 40
4.2 Normal ranges of neopterin concentrations in serum
pp.：
40 – 42
4.3 Normal ranges of neopterin concentrations in cerebrospinal fluid
pp.：
42 – 43
4.4 Normal ranges of neopterin concentrations in synovial fluid
pp.：
43 – 44
4.5 Normal ranges of neopterin concentrations in saliva
pp.：
44 – 45
5 Biosynthesis of Pteridines and the Human Immune System
pp.：
45 – 47
4.6 Discussion
pp.：
45 – 45
5.2 Cytokines and pteridine biosynthesis
pp.：
47 – 48
5.1 Immunological activation and cytokines
pp.：
47 – 47
5.3 Inducers of pteridine synthesis in human cells
pp.：
48 – 52
5.4 Cell culture techniques
pp.：
52 – 54
5.5 Determination of pteridines in cell homogenates and supernatants
pp.：
54 – 58
5.6 Enzyme activities of pteridine synthesis in cell extracts
pp.：
58 – 60
5.7 Biological significance of cytokine-induced pteridine synthesis
pp.：
60 – 62
6 Neopterin in Organ Transplantation
pp.：
66 – 69
6.1 Renal transplantation
pp.：
69 – 70
6.2 Transplantation of solid organs other than kidney
pp.：
70 – 82
6.3 Transplantation of bone marrow
pp.：
82 – 86
7 Neopterin in Autoimmune Diseases and Related Inflammatory Disorders
pp.：
88 – 91
7.1 Neopterin in rheumatoid arthritis
pp.：
91 – 92
7.2 Neopterin in inflammatory bowel diseases
pp.：
92 – 101
7.3 Neopterin in autoimmune diabetes
pp.：
101 – 109
7.4 Neopterin in autoimmune diseases of the thyroid
pp.：
109 – 111
7.5 Neopterin in systemic lupus erythematosus
pp.：
111 – 111
7.6 Neopterin in multiple sclerosis
pp.：
111 – 113
7.7 Neopterin in sarcoidosis
pp.：
113 – 115
7.8 Neopterin in celiac disease
pp.：
115 – 118
References
pp.：
118 – 119
8 Neopterin in Malignant Diseases
pp.：
119 – 123
8.1 Hematological malignancies
pp.：
123 – 124
8.2 Gynecological malignancies
pp.：
124 – 131
8.3 Malignancies of the urogenital tract
pp.：
131 – 158
8.4 Lung cancer
pp.：
158 – 162
8.5 Gastrointestinal, pancreatic and hepatic cancer
pp.：
162 – 169
8.6 Breast cancer
pp.：
169 – 175
8.7 Cancers of the head and neck region
pp.：
175 – 177
8.8 Malignant melanoma
pp.：
177 – 177
8.9 Neopterin in malignant diseases - a summary
pp.：
177 – 178
References
pp.：
178 – 179
9 Neopterin in Infectious Diseases
pp.：
179 – 183
9.1 Infections by viruses
pp.：
183 – 184
9.2 Neopterin during infection by human immunodeficiency virus type 1 (HIV-1) and the acquired immunodeficiency syndrome (AIDS)
pp.：
184 – 200
9.3 Infections by intracellular protozoa
pp.：
200 – 251
9.4 Infections by bacteria
pp.：
251 – 261
9.5 Neopterin during sepsis and trauma
pp.：
261 – 268
References
pp.：
268 – 271
10 Monitoring of Immunostimulatory Therapy
pp.：
271 – 279
References
pp.：
279 – 286
11 Neopterin in Transfusion Medicine
pp.：
286 – 289
References
pp.：
289 – 294
References
pp.：
295 – 299
Subject Index
pp.：
299 – 301
Neopterin
：Biochemistry - Methods - Clinical Application
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
